A citation-based method for searching scientific literature

Eduardo De Pablo-Fernandez, Raph Goldacre, Julia Pakpoor, Alastair J Noyce, Thomas T Warner. Neurology 2018
Times Cited: 108







List of co-cited articles
915 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Dilan Athauda, Kate Maclagan, Simon S Skene, Martha Bajwa-Joseph, Dawn Letchford, Kashfia Chowdhury, Steve Hibbert, Natalia Budnik, Luca Zampedri, John Dickson,[...]. Lancet 2017
339
32

Diabetes mellitus and Parkinson disease.
Gennaro Pagano, Sotirios Polychronis, Heather Wilson, Beniamino Giordano, Nicola Ferrara, Flavia Niccolini, Marios Politis. Neurology 2018
92
32

Type 2 diabetes and the risk of Parkinson's disease.
Gang Hu, Pekka Jousilahti, Siamak Bidel, Riitta Antikainen, Jaakko Tuomilehto. Diabetes Care 2007
289
28


Increased risk of Parkinson disease with diabetes mellitus in a population-based study.
Yu-Wan Yang, Teng-Fu Hsieh, Chia-Ing Li, Chiu-Shong Liu, Wen-Yuan Lin, Jen-Huai Chiang, Tsai-Chung Li, Cheng-Chieh Lin. Medicine (Baltimore) 2017
61
40

Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis.
Emanuele Cereda, Michela Barichella, Carlo Pedrolli, Catherine Klersy, Erica Cassani, Riccardo Caccialanza, Gianni Pezzoli. Diabetes Care 2011
137
23

Diabetes and risk of Parkinson's disease.
Qun Xu, Yikyung Park, Xuemei Huang, Albert Hollenbeck, Aaron Blair, Arthur Schatzkin, Honglei Chen. Diabetes Care 2011
163
22

Obesity, diabetes, and risk of Parkinson's disease.
Natalia Palacios, Xiang Gao, Marjorie L McCullough, Eric J Jacobs, Alpa V Patel, Tinisha Mayo, Michael A Schwarzschild, Alberto Ascherio. Mov Disord 2011
98
20

Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies.
Xuejing Yue, Hehua Li, Haiqing Yan, Ping Zhang, Li Chang, Tong Li. Medicine (Baltimore) 2016
79
25

Diabetes and the risk of developing Parkinson's disease in Denmark.
Eva Schernhammer, Johnni Hansen, Kathrine Rugbjerg, Lene Wermuth, Beate Ritz. Diabetes Care 2011
117
19

Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications.
Yu Sun, Ya-Hui Chang, Hua-Fen Chen, Ying-Hwa Su, Hui-Fang Su, Chung-Yi Li. Diabetes Care 2012
121
18

Exenatide and the treatment of patients with Parkinson's disease.
Iciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, Atbin Djamshidian, Peter Ell, Therese Soderlund, Peter Whitton, Richard Wyse, Tom Isaacs, Andrew Lees,[...]. J Clin Invest 2013
278
16

Dementia is associated with insulin resistance in patients with Parkinson's disease.
Domenico Bosco, Massimiliano Plastino, Dario Cristiano, Carmela Colica, Caterina Ermio, Matteo De Bartolo, Pasquale Mungari, Giulia Fonte, Domenico Consoli, Arturo Consoli,[...]. J Neurol Sci 2012
80
20

Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.
Istvan Horvath, Pernilla Wittung-Stafshede. Proc Natl Acad Sci U S A 2016
81
19

Diabetes is associated with postural instability and gait difficulty in Parkinson disease.
Vikas Kotagal, Roger L Albin, Martijn L T M Müller, Robert A Koeppe, Kirk A Frey, Nicolaas I Bohnen. Parkinsonism Relat Disord 2013
61
24


Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.
Ivan Martinez-Valbuena, Irene Amat-Villegas, Rafael Valenti-Azcarate, Maria Del Mar Carmona-Abellan, Irene Marcilla, Maria-Teresa Tuñon, Maria-Rosario Luquin. Acta Neuropathol 2018
30
46

Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View.
Alice Biosa, Tiago F Outeiro, Luigi Bubacco, Marco Bisaglia. Mol Neurobiol 2018
38
34

Clinical features of Parkinson disease when onset of diabetes came first: A case-control study.
E Cereda, M Barichella, E Cassani, R Caccialanza, G Pezzoli. Neurology 2012
90
14

Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease.
Jane A Driver, Ashley Smith, Julie E Buring, J Michael Gaziano, Tobias Kurth, Giancarlo Logroscino. Diabetes Care 2008
105
13

Shared dysregulated pathways lead to Parkinson's disease and diabetes.
Jose A Santiago, Judith A Potashkin. Trends Mol Med 2013
137
13

Association between Parkinson's disease and diabetes: Data from NEDICES study.
E De Pablo-Fernandez, F Sierra-Hidalgo, J Benito-León, F Bermejo-Pareja. Acta Neurol Scand 2017
35
37

Parkinson's disease, insulin resistance and novel agents of neuroprotection.
Iciar Aviles-Olmos, Patricia Limousin, Andrew Lees, Thomas Foltynie. Brain 2013
185
12

Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies.
Lin Lu, Deng-Lei Fu, Hui-Qin Li, Ai-Ju Liu, Ji-Huang Li, Guo-Qing Zheng. PLoS One 2014
71
16

Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes.
Ruth Brauer, Li Wei, Tiantian Ma, Dilan Athauda, Christine Girges, Nirosen Vijiaratnam, Grace Auld, Cate Whittlesea, Ian Wong, Tom Foltynie. Brain 2020
42
28

Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease.
Kelly Claire Simon, Honglei Chen, Michael Schwarzschild, Alberto Ascherio. Neurology 2007
161
11

Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort.
Mark L Wahlqvist, Meei-Shyuan Lee, Chih-Cheng Hsu, Shao-Yuan Chuang, Jiunn-Tay Lee, Hsin-Ni Tsai. Parkinsonism Relat Disord 2012
145
11

Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.
Nicolaas I Bohnen, Vikas Kotagal, Martijn L T M Müller, Robert A Koeppe, Peter J H Scott, Roger L Albin, Kirk A Frey, Myria Petrou. Parkinsonism Relat Disord 2014
44
25

Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.
Steven E Arnold, Zoe Arvanitakis, Shannon L Macauley-Rambach, Aaron M Koenig, Hoau-Yan Wang, Rexford S Ahima, Suzanne Craft, Sam Gandy, Christoph Buettner, Luke E Stoeckel,[...]. Nat Rev Neurol 2018
497
10

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
10

Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease.
Seung Pil Yun, Tae-In Kam, Nikhil Panicker, SangMin Kim, Yumin Oh, Jong-Sung Park, Seung-Hwan Kwon, Yong Joo Park, Senthilkumar S Karuppagounder, Hyejin Park,[...]. Nat Med 2018
412
10

Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease.
Iciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, Atbin Djamshidian, Joshua Kahan, Peter Ell, Peter Whitton, Richard Wyse, Tom Isaacs, Andrew Lees,[...]. J Parkinsons Dis 2014
160
10


Diabetes preceding Parkinson's disease onset. A case-control study.
Marco D'Amelio, Paolo Ragonese, Graziella Callari, Norma Di Benedetto, Barbara Palmeri, Valeria Terruso, Giuseppe Salemi, Giorgia Famoso, Paolo Aridon, Giovanni Savettieri. Parkinsonism Relat Disord 2009
48
20

Parkinson disease.
Werner Poewe, Klaus Seppi, Caroline M Tanner, Glenda M Halliday, Patrik Brundin, Jens Volkmann, Anette-Eleonore Schrag, Anthony E Lang. Nat Rev Dis Primers 2017
10

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.
Yazhou Li, TracyAnn Perry, Mark S Kindy, Brandon K Harvey, David Tweedie, Harold W Holloway, Kathleen Powers, Hui Shen, Josephine M Egan, Kumar Sambamurti,[...]. Proc Natl Acad Sci U S A 2009
405
9

Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease.
Göran Bertilsson, Cesare Patrone, Olof Zachrisson, Annica Andersson, Karin Dannaeus, Jessica Heidrich, Jarkko Kortesmaa, Alex Mercer, Elisabet Nielsen, Harriet Rönnholm,[...]. J Neurosci Res 2008
240
9


Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease: A Systematic Review and Meta-analysis.
Xiao-Yan Qin, Shu-Ping Zhang, Chang Cao, Y Peng Loh, Yong Cheng. JAMA Neurol 2016
225
9

Case-control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan.
Yoshihiro Miyake, Keiko Tanaka, Wakaba Fukushima, Satoshi Sasaki, Chikako Kiyohara, Yoshio Tsuboi, Tatsuo Yamada, Tomoko Oeda, Takami Miki, Nobutoshi Kawamura,[...]. J Neurol Sci 2010
84
10

A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.
Dong Seok Kim, Ho-Il Choi, Yun Wang, Yu Luo, Barry J Hoffer, Nigel H Greig. Cell Transplant 2017
72
12

Glucose dysregulation in Parkinson's disease: Too much glucose or not enough insulin?
Ana Marques, Frédéric Dutheil, Elodie Durand, Isabelle Rieu, Aurélien Mulliez, Maria Livia Fantini, Yves Boirie, Franck Durif. Parkinsonism Relat Disord 2018
20
45

Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial.
Dilan Athauda, Seema Gulyani, Hanuma Kumar Karnati, Yazhou Li, David Tweedie, Maja Mustapic, Sahil Chawla, Kashfia Chowdhury, Simon S Skene, Nigel H Greig,[...]. JAMA Neurol 2019
94
9

Glitazone use associated with reduced risk of Parkinson's disease.
Brage Brakedal, Irene Flønes, Simone F Reiter, Øivind Torkildsen, Christian Dölle, Jörg Assmus, Kristoffer Haugarvoll, Charalampos Tzoulis. Mov Disord 2017
63
14

Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study.
Ruth Brauer, Krishnan Bhaskaran, Nishi Chaturvedi, David T Dexter, Liam Smeeth, Ian Douglas. PLoS Med 2015
81
11

The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease.
Julia L Y Cheong, Eduardo de Pablo-Fernandez, Thomas Foltynie, Alastair J Noyce. J Parkinsons Dis 2020
33
27

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
8


Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease.
Alexander Harkavyi, Amjad Abuirmeileh, Rebecca Lever, Ann E Kingsbury, Christopher S Biggs, Peter S Whitton. J Neuroinflammation 2008
190
8

Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease.
I Moroo, T Yamada, H Makino, I Tooyama, P L McGeer, E G McGeer, K Hirayama. Acta Neuropathol 1994
115
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.